Moreover, a recent study proposed that targeting the S1P/S1P receptor 2-signaling pathway in the lung may provide a novel therapeutic perspective in pneumonia for the prevention of acute lung injury.[28]. Here, S1PR2 is linked to susceptibility to pneumonia measurement.